Osteoporosis Pathophysiology

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/55

flashcard set

Earn XP

Description and Tags

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

56 Terms

1
New cards

What is the role of bones?

  • mechanical support for movement

  • protects the viscera

  • determines body shape and size

  • mineral homeostasis

  • houses hematopoietic elements

2
New cards

What is the role of collagen in bone?

flexibility, energy absorbing capability

3
New cards

What is the role of minerals in the bone?

calcium hydroxyapatite, gives bone strength and hardness

4
New cards

What can imbalances in the bone components lead to?

impaired bone quality

5
New cards

What are the two types of bone?

cortical bone

trabecular bone

6
New cards

What is cortical bone?

outside shell

80% of bone

long bones

7
New cards

What is trabecular bone?

inside bone with trabeculae, spaces filled with red or white marrow

vertebrae and ends of long bones

remodeled more rapidly than cortical bone

8
New cards

True or False: bone is a dynamic tissue that is continuously resorbed, renewed, and remodeled

true

9
New cards

What processes are a part of the continuous, lifelong bone development and homeostasis process?

balances bone reabsorption and formation

maintains calcium and phosphate balance

osteoblasts and osteoclasts involved

10
New cards

When is peak bone mass acieved?

early adulthood (18-25)

11
New cards

True or False: the higher the peak bone mass, the more bone a person can lose before being at an increased risk of fracture

true

12
New cards

What factors determine peak bone mass?

genetics, nutritional intake, physical activity, adverse lifestyle practices, hormonal status, certain conditions and meds

13
New cards

What are osteoclasts?

specialized for bone resorption

break down bone matrix by secreting collagenase and proteases

14
New cards

What are osteoblasts?

specialized for bone formation

lay down bone matrix (type I collagen) by secreting proteins and proteoglycans

15
New cards

What are osteocytes?

mechanoreceptors; detect strain on bone and signal changes in bone remodeling

16
New cards

Why is bone remodeling triggered?

to repair damage to bone microarchitecture and to support calcium hemostasis

17
New cards

What happens in the resorptive phase of bone remodeling?

osteoclasts resorb bone

18
New cards

What happens in the formation phase of bone remodeling?

osteoblast form bone

19
New cards

What happens in the quiescent phase of bone remodeling?

bone unit inactivity

20
New cards

What is bone remodeling triggered by?

stress, micro-fractures, biofeedback responsive to cytokines and growth factors, and certain medical conditions and medications

21
New cards

What hormones is bone remodeling influenced by?

estrogen, testosterone

22
New cards

What is RANK ligand?

a key regulator of osteoclast differentiation, activation and function

23
New cards

Where is RANKL secreted from?

osteoblasts and osteocytes

24
New cards

What does RANK ligand bind to?

RANK receptor on osteoclast precursor cells

25
New cards

What is osteoprotegerin (OPG)?

protein produced by osteoblasts and osteocytes

26
New cards

What does OPG inhibit?

RANK ligand

27
New cards

What does OPG do?

prevent osteoclast activation and protects the balance of osteoblast/clast activeation

28
New cards

What factors favor osteoclast activity?

inflammatory cytokines

parathyroid hormone

sclerostin

glucocorticoids

29
New cards

What factors favor osteoblast activity?

estrogen

calcitonin

osteoprotegerin

vitamin D

30
New cards

When does the “scale tip” towards bone resorption?

beginning in the 4th decade (30s)

31
New cards

How does destruction of bone microarchitecture occur?

decreased tensile strength, decreased bone mineral density, increased fracture risk

32
New cards

What is osteoporosis?

low bone mass and microarchitectural deterioration of bone tissue leading to enhanced bone fragility and consequent increase in fracture risk (4-fold)

33
New cards

What is osteopenia?

low bone mass; 1.8x risk of fracture

34
New cards

True or False: osteoporosis is often a silent disease until it is complicated by low-trauma fractures

true

35
New cards

What are common fracture sites for osteoporotic fractures?

hip, wrist, and spine

36
New cards

How do osteoporotic fractures usually occur?

results from a fall from standing height or less

37
New cards

What are the odds for women to experience a fracture?

50% of women over the age of 50 will experience a fracture in her lifetime

38
New cards

What % of men usually experience a fracture?

20

39
New cards

What is the pathogenesis of osteoporosis?

after peak bone mass is attained, a small deficit in bone formation accrues with every remodeling cycle

40
New cards

What is age-related osteoporosis?

age-related bone loss is normal and somewhat predictable; time to significant bone loss depends on peak bone mass

41
New cards

What is post-menopausal osteoporosis?

bone loss increases following menopause; protective effects of estrogen are lost/decreased

42
New cards

What are the three factors that lead to peak bone mass?

genetic factors, nutrition, physical activity

43
New cards

What occurs in menopause that leads to osteoporosis?

decreased serum estrogen, increased cytokines (IL-1, IL-6, TNF levels), increased expression of RANK, RANKL, and increased osteoclast activity

44
New cards

What occurs in aging that leads to osteoporosis?

decreased replicative activity of osteoprogenitor cells, decreased synthetic activity of osteoblasts, decreased biologic activity of matrix-bound growth factors, and reduced physical activity

45
New cards

What differs in postmenopausal and age-related osteoporosis?

site of fracture and selection of treatment (not impacted as much)

46
New cards

What kind of fractures are more common in post-menopausal osteoporosis?

compression fractures of vertebrae

47
New cards

Which medications/therapies inhibit bone resorption/ increase osteoclast acitivty?

bisphosphonates, RANKL inhibitors, estrogen or estrogen like agents, calcitonin, sclerostin monoclonal antibodies

48
New cards

What medications/therapies increase bone formation/stimulate osteoblast activity?

parathyroid hormone analogs, sclerostin monoclonal antibodies

49
New cards

What is the drug target of bisphosphonates?

bind to hydroxyapatite and inhibit osteoclast function

50
New cards

What is the drug target of estrogen agonist/antagonists (EAAs) or tissue specific estrogen complex (TSEC)?

acts as estrogen agonist in bine

51
New cards

What is the drug target of denosumab?

prevents RANKL from activating RANK, inhibiting osteoclast formation

52
New cards

What is the drug target of teriparatide/abaloparatide (synthetic PTH)?

stimulates new bone formation by preferential stimulation of osteoblast activity over osteoclast activity

53
New cards

What is the drug target of romosozumab?

monoclonal antibody against sclerostin, prevents inhibition of bone formation and decreases bone resorption

54
New cards

What are risk factors for osteoporosis?

low BMD, female sex, advanced age, race/ethnicity, history of previous fragility fracture as an adult, low body weight of BMI, premature menopause (<45), current cigarette smoking, alcohol intake of 3 or more drinks/day, low calcium intake, vitamin D insufficiency or deficiency, low physical activity or immobilization, cognitive impairment, recent falls, impaired vision

55
New cards

What medical conditions are associated with osteoporosis?

ovarian failure, testosterone deficiency, hyperthyroidism, primary hyperparathyroidism, diabetes, nutritional disorders, malabsorptive states, vitamin D deficiency, inflammatory diseases, chronic illness (CKD, malignancies, COPD), conditions causing immobility, genetic diseases (cystic fibrosis)

56
New cards

What medications are associated with osteoporosis?

glucocorticoids, antiseizure therapy, aromatase inhibitors, depo shot, heparin (UF> LMWH), PPIs, TZDs, SGLT-2i (canagliflozin)